BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 16270646)

  • 1. Acquired Glanzmann's thrombasthenia variant and immune thrombocytopenia in a renal transplant recipient receiving tacrolimus.
    Morath C; Hoffmann T; Kirchhoff EM; Sis J; Zeier M; Scharf RE; Andrassy K
    Thromb Haemost; 2005 Oct; 94(4):879-80. PubMed ID: 16270646
    [No Abstract]   [Full Text] [Related]  

  • 2. Acquired Glanzmann's thrombasthenia as part of multiple-autoantibody syndrome in a pediatric heart transplant patient.
    Rawal A; Sarode R; Curtis BR; Karandikar NJ; Friedman K; Rogers ZR
    J Pediatr; 2004 May; 144(5):672-4. PubMed ID: 15127012
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A case of tacrolimus (FK506)-induced pancreatitis and fatality 2 years postcadaveric renal transplant.
    Ogunseinde BA; Wimmers E; Washington B; Iyob M; Cropper T; Callender CO
    Transplantation; 2003 Jul; 76(2):448. PubMed ID: 12883222
    [No Abstract]   [Full Text] [Related]  

  • 4. Acquired Glanzmann's thrombasthenia without thrombocytopenia: a severe acquired autoimmune bleeding disorder.
    Tholouli E; Hay CR; O'Gorman P; Makris M
    Br J Haematol; 2004 Oct; 127(2):209-13. PubMed ID: 15461628
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute renal failure in a renal allograft recipient treated with intravenous immunoglobulin.
    Tsinalis D; Dickenmann M; Brunner F; Gürke L; Mihatsch M; Nickeleit V
    Am J Kidney Dis; 2002 Sep; 40(3):667-70. PubMed ID: 12200824
    [No Abstract]   [Full Text] [Related]  

  • 6. [Interaction between tacrolimus and theophylline in a renal transplant recipient: a case report].
    Gaïes E; Trabelsi S; Salouage I; Jebabli N; Charfi R; Lakhal M; Klouz A
    Therapie; 2011; 66(6):553-4. PubMed ID: 22186080
    [No Abstract]   [Full Text] [Related]  

  • 7. Late-onset tacrolimus-associated cerebellar atrophia in a heart transplant recipient.
    Kaczmarek I; Schmauss D; Sodian R; Beiras-Fernandez A; Oberhoffer M; Daebritz S; Schoenberg SO; Reichart B
    J Heart Lung Transplant; 2007 Jan; 26(1):89-92. PubMed ID: 17234523
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Normocalcaemic normomagnesaemic tetany with tacrolimus.
    Aiyangar A; Chowdhary P; Rao K; Kiran K
    Nephrology (Carlton); 2011 Nov; 16(8):784-5. PubMed ID: 22029645
    [No Abstract]   [Full Text] [Related]  

  • 9. Serious interaction between tacrolimus FK506 and chloramphenicol in a kidney-pancreas transplant recipient.
    Bakri R; Breen C; Maclean D; Taylor J; Goldsmith D
    Transpl Int; 2003 Jun; 16(6):441-3. PubMed ID: 12819878
    [No Abstract]   [Full Text] [Related]  

  • 10. Can daclizumab reduce acute rejection and improve long-term renal function in tacrolimus-based primary renal transplant recipients?
    Cheung CY; Liu YL; Wong KM; Chan HW; Chan YH; Wong HS; Chak WL; Choi KS; Chau KF; Shek CC; Li CS
    Nephrology (Carlton); 2008 Jun; 13(3):251-5. PubMed ID: 18221256
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fever of unknown origin in renal transplant patients with tacrolimus.
    Hochegger K; Rudnicki M; Auinger M; Mark W; Margreiter R; Mayer G; Rosenkranz AR
    Clin Transplant; 2009; 23(4):575-9. PubMed ID: 19191804
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Paired kidney analysis of tacrolimus and cyclosporine microemulsion-based therapy in Chinese cadaveric renal transplant recipients.
    Cheung CY; Wong KM; Chan HW; Liu YL; Chan YH; Wong HS; Chak WL; Choi KS; Chau KF; Li CS
    Transpl Int; 2006 Aug; 19(8):657-66. PubMed ID: 16827683
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of MDR1 and CYP3A5 on the oral clearance of tacrolimus and tacrolimus-related renal dysfunction in adult living-donor liver transplant patients.
    Fukudo M; Yano I; Yoshimura A; Masuda S; Uesugi M; Hosohata K; Katsura T; Ogura Y; Oike F; Takada Y; Uemoto S; Inui K
    Pharmacogenet Genomics; 2008 May; 18(5):413-23. PubMed ID: 18408564
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiac hypertrophy in liver transplant recipients: tacrolimus, cyclosporine or both?
    Therapondos G; Plevris JN; Dollinger MM; Hayes PC; Flapan AD
    Transplantation; 2003 Jul; 76(2):446-7; author reply 447-8. PubMed ID: 12883220
    [No Abstract]   [Full Text] [Related]  

  • 15. Regression of BCC following immunosuppression withdrawal in a renal transplant recipient.
    Rawlins J; Platt A; Gowda P
    Clin Exp Dermatol; 2006 Sep; 31(5):717-8. PubMed ID: 16901322
    [No Abstract]   [Full Text] [Related]  

  • 16. Pregnancy in mother with Glanzmann's thrombasthenia and isoantibody against GPIIb-IIIa: Is there a foetal risk?
    Léticée N; Kaplan C; Lémery D
    Eur J Obstet Gynecol Reprod Biol; 2005 Aug; 121(2):139-42. PubMed ID: 16054952
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kaposi's sarcoma occurring in a cardiac transplant patient on tacrolimus.
    Chua R; Macdonald P
    Heart Lung Circ; 2006 Oct; 15(5):340-1. PubMed ID: 16781193
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bilateral femoral capital avascular necrosis in a renal transplant recipient on tacrolimus-based immunosuppression.
    Nayagam LS; Rajan SG; Khandelwal N; Sen R; Kohli HS; Sud K; Gupta KL; Sakhuja V; Jha V
    Nephrol Dial Transplant; 2005 Oct; 20(10):2262-4. PubMed ID: 16030048
    [No Abstract]   [Full Text] [Related]  

  • 19. Severe neutropenia and thrombocytopenia following cardiac transplantation in a child.
    Chitlur M; Abella E; Singh TP; Savaşan S
    Pediatr Transplant; 2005 Feb; 9(1):94-6. PubMed ID: 15667619
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is acute rejection the key predictor for long-term outcomes after renal transplantation when comparing calcineurin inhibitors?
    Nashan B
    Transplant Rev (Orlando); 2009 Jan; 23(1):47-52. PubMed ID: 19027616
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.